1,364.01
0.00
(0.00%)
At close: July 23 at 12:13:30 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 12 | 19 | 19 |
| Avg. Estimate | 1.63B | 1.56B | 6.24B | 6.48B |
| Low Estimate | 1.61B | 1.53B | 6.22B | 6.32B |
| High Estimate | 1.64B | 1.6B | 6.25B | 6.69B |
| Year Ago Sales | 1.58B | 1.52B | 6.07B | 6.24B |
| Sales Growth (year/est) | 2.84% | 2.22% | 2.90% | 3.85% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FTV.MX | -- | -- | -- | -- |
| S&P 500 | 9.47% | 11.36% | 13.97% | 13.61% |
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 1/15/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/8/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/7/2025 |
| Maintains | Truist Securities: Buy to Buy | 12/19/2024 |
| Downgrade | Citigroup: Buy to Neutral | 12/9/2024 |
| Downgrade | Argus Research: Buy to Hold | 11/18/2024 |